4-anilino-3-quinolinecarbonitriles for the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4709 (2006.01) A61K 31/496 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2543163

Compounds of formula (I) wherein n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-diCI, 5-OMe; 2,4-diCI; 3,4,5-triOMe; 3-CI, 5-OMe; 2-Me, 5-OMe; 2,4-di- Me; 2,4-diMe-5-OMe, 2,4-diCI, 5-OEt; R2 is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof are useful for the treatment of chronic myelogenous leukemia (CML).

La présente invention concerne des composés représentés par la formule (I), dans laquelle, n représente un entier relatif compris entre 1-3; X représente N, CH, pour autant que lorsque X représente N, n représente 2 ou 3; R représente alkyle comprenant de 1 à 3 atomes de carbone; R?1¿ représente 2,4-diCI, 5-OMe; 2,4-diCI; 3,4,5-triOMe; 3-CI, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCI, 5-OEt; R?2¿ représente alkyle comprenant de 1 à 2 atomes de carbone, et des sels pharmaceutiquement acceptables, lesquels sont utilisés pour le traitement de la leucémie myéloïde chronique (CML).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

4-anilino-3-quinolinecarbonitriles for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-anilino-3-quinolinecarbonitriles for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-anilino-3-quinolinecarbonitriles for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1701640

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.